Shopping Cart
- Remove All
- Your shopping cart is currently empty
Utibapril, an inhibitor of angiotensin-converting enzyme (ACE), exhibits antihypertensive activities.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Utibapril, an inhibitor of angiotensin-converting enzyme (ACE), exhibits antihypertensive activities. |
In vivo | Utibapril significantly inhibits plasma, renal, and vascular ACE but not ventricular ACE activity. Vascular ACE activity is significantly inhibited by Utibapril (2 μg/kg/day), and Utibapril (250 μg/kg/day) results in significant inhibition of plasma ACE. Additionally, angiotensin I-induced decreases in coronary flow in the isolated heart are significantly inhibited after treatment with higher doses of Utibapril [1]. FPL 63547 is rapidly and extensively excreted as the diacid in bile but appears in urine in negligible amounts [2]. |
Alias | FPL 63547 |
Molecular Weight | 449.56 |
Formula | C22H31N3O5S |
Cas No. | 109683-61-6 |
Relative Density. | 1.24g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.